2026 Global: Cardiac Arrhythmia Monitoring Devices Market-Competitive Review (2032) report
Description
The 2026 Global: Cardiac Arrhythmia Monitoring Devices Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cardiac arrhythmia monitoring devices market by geography and historical trend. The scope of the report extends to sizing of the cardiac arrhythmia monitoring devices market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The Cardiac Arrhythmia Monitoring Devices Market features dominant players like Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., and GE HealthCare Technologies Inc. as the top ten companies, based on market share, innovation, and global presence. Medtronic leads with a commanding position, offering advanced implantable cardiac monitors like the BIOMONITOR IV and comprehensive solutions for arrhythmia detection, emphasizing therapeutic consistency and device optimization across cardiovascular applications. Abbott Laboratories excels in high-tech segments with ECG monitoring tools and electrophysiology systems, including the Volt PFA platform for precise arrhythmia management. Boston Scientific holds significant share through premium devices like the FARAPULSE PFA system and Rhythmia mapping technology, focusing on safe atrial fibrillation treatments. Koninklijke Philips N.V. provides reliable monitoring solutions with professional support, integrating AI for enhanced diagnostics.
iRhythm Technologies, Inc., Biotronik SE & Co. KG, AliveCor Inc., and ZOLL Medical Corporation complete the leading group, driving innovation in wearable and ambulatory monitoring. iRhythm pioneered AI-powered ECG systems like the Zio patch, launching long-term monitoring services in Japan in May 2025 for up to 14 days of continuous analysis. Biotronik specializes in implantable devices with performance enhancements, contributing to moderately consolidated market dynamics alongside larger peers. AliveCor transforms smartphones into clinical ECG recorders using machine learning for proactive heart care, recognized globally for mobile arrhythmia detection. ZOLL, part of Asahi Kasei, offers robust monitoring portfolios, including recent advancements in remote ECG, bolstering its role in high-reliability segments. These firms collectively control key areas like Holter monitors, telemetry, and AI analytics, with the market growing at a 15.23% CAGR through 2032.
Market concentration remains moderate, blending established giants with agile innovators amid rising demand for AI-driven, non-invasive devices. GE HealthCare rounds out the top ten with diagnostic imaging and monitoring integrations, supporting extended arrhythmia detection. Recent activities, such as iRhythm's Japan expansion and Vivalink's ambulatory solutions, underscore competitive strategies in partnerships and FDA clearances. Leaders invest heavily in pulsed field ablation and wearable tech, addressing atrial fibrillation and ventricular tachycardia while expanding in emerging regions. This landscape fosters advancements in accuracy, patient convenience, and cost-efficiency, positioning these companies for sustained dominance.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cardiac arrhythmia monitoring devices market by geography and historical trend. The scope of the report extends to sizing of the cardiac arrhythmia monitoring devices market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
The Cardiac Arrhythmia Monitoring Devices Market features dominant players like Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., and GE HealthCare Technologies Inc. as the top ten companies, based on market share, innovation, and global presence. Medtronic leads with a commanding position, offering advanced implantable cardiac monitors like the BIOMONITOR IV and comprehensive solutions for arrhythmia detection, emphasizing therapeutic consistency and device optimization across cardiovascular applications. Abbott Laboratories excels in high-tech segments with ECG monitoring tools and electrophysiology systems, including the Volt PFA platform for precise arrhythmia management. Boston Scientific holds significant share through premium devices like the FARAPULSE PFA system and Rhythmia mapping technology, focusing on safe atrial fibrillation treatments. Koninklijke Philips N.V. provides reliable monitoring solutions with professional support, integrating AI for enhanced diagnostics.
iRhythm Technologies, Inc., Biotronik SE & Co. KG, AliveCor Inc., and ZOLL Medical Corporation complete the leading group, driving innovation in wearable and ambulatory monitoring. iRhythm pioneered AI-powered ECG systems like the Zio patch, launching long-term monitoring services in Japan in May 2025 for up to 14 days of continuous analysis. Biotronik specializes in implantable devices with performance enhancements, contributing to moderately consolidated market dynamics alongside larger peers. AliveCor transforms smartphones into clinical ECG recorders using machine learning for proactive heart care, recognized globally for mobile arrhythmia detection. ZOLL, part of Asahi Kasei, offers robust monitoring portfolios, including recent advancements in remote ECG, bolstering its role in high-reliability segments. These firms collectively control key areas like Holter monitors, telemetry, and AI analytics, with the market growing at a 15.23% CAGR through 2032.
Market concentration remains moderate, blending established giants with agile innovators amid rising demand for AI-driven, non-invasive devices. GE HealthCare rounds out the top ten with diagnostic imaging and monitoring integrations, supporting extended arrhythmia detection. Recent activities, such as iRhythm's Japan expansion and Vivalink's ambulatory solutions, underscore competitive strategies in partnerships and FDA clearances. Leaders invest heavily in pulsed field ablation and wearable tech, addressing atrial fibrillation and ventricular tachycardia while expanding in emerging regions. This landscape fosters advancements in accuracy, patient convenience, and cost-efficiency, positioning these companies for sustained dominance.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.